Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Berberine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Optimized catalytic transfer hydrogenation route ensures high purity dihydroberberine. Significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN1190425C reveals novel sulfation methods for berberine metabolites, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel patent CN119954798A offers high purity Berberine Hydrochloride synthesis. Reduces heavy metal risks and improves supply chain reliability for pharmaceutical intermediates.
Novel patent CN119080622A enables metal-free isoquinolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced iridium-catalyzed protocol for high-purity isoquinoline intermediates. Enables cost reduction in alkaloid manufacturing and scalable supply chain solutions.
Patent CN108997332B reveals a safe, high-yield catalytic transfer hydrogenation route for dihydroberberine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111205285B reveals a novel acetone adduct method for berberine purification, ensuring <0.1% single impurities and offering significant cost reduction in API manufacturing.
Novel berberine-platinum antitumor complex synthesis via mild coordination. Offers high purity, reduced toxicity, and cost-effective manufacturing for global pharma supply chains.
Patent CN105801573B reveals high-yield cyclization for Berberine intermediates. Offers scalable, cost-effective manufacturing solutions for global pharmaceutical supply chains.
Novel C-H activation synthesis of high-B-ring berberine derivatives offers potent IDO1/TDO inhibition for oncology drug development.
Patent CN119709674A reveals efficient BBE mutant for (S)-Scolerine. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
New patent CN121045172A reveals copper-catalyzed route for berberine. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1156474C details novel chiral isoquinoline synthesis offering improved solubility and bioavailability for cardiovascular drug manufacturing.
Patent CN1403456A details a novel resolution and quaternization process for chiral tetrahydroberberine, offering cost reduction in cardiovascular drug manufacturing and enhanced supply chain reliability.
Patent CN104529994A reveals a high-yield synthesis route for piperonyl ethylamine. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.
Patent CN101245064A details a novel six-step synthesis for berberine hydrochloride, offering high yields and eliminating heavy metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Novel patent CN114315823B enables safer berberine intermediate production without cyanide. Reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers seeking high purity.
Solve high-cost, hazardous synthesis of berberine intermediates. Our CDMO expertise enables safe, scalable production with 95%+ purity and 70%+ yield. Reduce supply chain risks.